Journal
EMBO JOURNAL
Volume 27, Issue 18, Pages 2432-2443Publisher
WILEY
DOI: 10.1038/emboj.2008.163
Keywords
4E-BP; dopaminergic neurodegeneration; LRRK2; Parkinson's disease; protein translation
Categories
Funding
- NIH [R21 NS056878-01, R01 AR054926-01]
- McKnight, Beckman and Sloan Foundations
- Naito Foundation
- Special Coordination Funds for Promoting Science and Technology
- MEXT in Japan
Ask authors/readers for more resources
Dominant mutations in leucine-rich repeat kinase 2 (LRRK2) are the most frequent molecular lesions so far found in Parkinson's disease (PD), an age-dependent neurodegenerative disorder affecting dopaminergic (DA) neuron. The molecular mechanisms by which mutations in LRRK2 cause DA degeneration in PD are not understood. Here, we show that both human LRRK2 and the Drosophila orthologue of LRRK2 phosphorylate eukaryotic initiation factor 4E (eIF4E)-binding protein (4E-BP), a negative regulator of eIF4E-mediated protein translation and a key mediator of various stress responses. Although modulation of the eIF4E/4E-BP pathway by LRRK2 stimulates eIF4E-mediated protein translation both in vivo and in vitro, it attenuates resistance to oxidative stress and survival of DA neuron in Drosophila. Our results suggest that chronic inactivation of 4E-BP by LRRK2 with pathogenic mutations deregulates protein translation, eventually resulting in age-dependent loss of DA neurons.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available